Seminars in Fetal & Neonatal Medicine
Volume 13, Issue 2 , Pages 76-83 , April 2008

Non-invasive prenatal diagnosis of single gene disorders: How close are we?

  • Gail Norbury

      Affiliations

    • NE Thames Regional Molecular Genetics Laboratory, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 207 905 2659; fax: +44 207 813 8196.
    • ,
  • Chris J. Norbury

      Affiliations

    • Sir William Dunn School of Pathology, University of Oxford, Oxford, UK

References 

  1. Alberry M, Maddocks D, Jones M, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn. 2007 May;27(5):415–418
  2. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non-invasive prenatal diagnosis. Am J Hum Genet. 1998;62:768–775
  3. Bischoff FZ, Lewis DE, Simpson JL. Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update. 2005 Jan–Feb;11(1):59–67
  4. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem. 2000;46:1832–1834
  5. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999;64:218–224
  6. Chan KC, Zhang J, Hui AB, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem. 2004 Jan;50(1):88–92
  7. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem. 2004 Jun;50(6):1002–1011
  8. Li Y, Holzgreve W, Page-Christiaens GC, Gille JJ, Hahn S. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma-case report. Prenat Diagn. 2004;24:896–898
  9. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA. 2005 Feb 16;293(7):843–849
  10. Daniels G, Finning K, Martin P, Summers J. Fetal blood group genotyping: present and future. Ann N Y Acad Sci. 2006 Sep;1075:88–95
  11. Hyett JA, Gardener G, Stojilkovic-Mikic T, et al. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn. 2005;25:1111–1116
  12. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet. 2000 Sep 30;356(9236):1170
  13. Li Y, Page-Christiaens GC, Gille JJ, Holzgreve W, Hahn S. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn. 2007 Jan;27(1):11–17
  14. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet. 2002 Sep 28;360(9338):998–1000
  15. Ding C, Chiu RW, Lau TK, et al. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10762–10767
  16. Chiu RW, Lau TK, Cheung PT, Gong ZQ, Leung TN, Lo YM. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem. 2002 May;48(5):778–780
  17. González-González MC, García-Hoyos M, Trujillo MJ, et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn. 2002 Oct;22(10):946–948
  18. González-González MC, Trujillo MJ, Rodríguez de Alba M, et al. Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn. 2003 Mar;23(3):232–234
  19. González-González MC, Trujillo MJ, Rodríguez de Alba M, Ramos C. Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR. Neurology. 2003 Apr 8;60(7):1214–1215
  20. Lazaros L, Hatzi E, Bouba I, Paraskevaidis E, Georgiou I. Non-invasive prenatal detection of paternal origin hb lepore in a male fetus at the 7th week of gestation. Fetal Diagn Ther. 2006;21(6):506–509
  21. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem. 2000 Feb;46(2):301–302
  22. Houfflin-Debarge V, O'Donnell H, Overton T, Bennett PR, Fisk NM. High sensitivity of fetal DNA in plasma compared to serum and nucleated cells using unnested PCR in maternal blood. Fetal Diagn Ther. 2000 Mar–Apr;15(2):102–107
  23. Bischoff FZ, Dang DX, Marquez-Do D, et al. Detecting fetal DNA from dried maternal blood spots: another step towards broad scale non-invasive prenatal genetic screening and feasible testing. Reprod Biomed Online. 2003 Apr–May;6(3):349–351
  24. Alizadeh M, Bernard M, Danic B, et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood. 2002 Jun 15;99(12):4618–4625
  25. Chim SS, Tong YK, Chiu RW, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14753–14758
  26. Chan KC, Ding C, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem. 2006 Dec;52(12):2211–2218
  27. Chitty L, Hogg J, Martin PG, Meaney C, Norbury G. Effectiveness of non-invasive prenatal diagnosis using free fetal DNA in the maternal circulation. J Med Genet. 2007 Sep;43(S1):SP43
  28. Verstraete L, Costa JM, Chantot-Bastaraud S, et al. Finding a single XY cell among XX cells in amniotic fluid by FISH: a possible consequence of a vanishing male twin?. Prenat Diagn. 2007;27(1):85–86
  29. Landy HJ, Keith LG. The vanishing twin: a review. Hum Reprod Update. 1998 Mar–Apr;4(2):177–183
  30. Flori E, Doray B, Gautier E, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Hum Reprod. 2004 Mar;19(3):723–724
  31. Masuzaki H, Miura K, Yoshiura KI, Yoshimura S, Niikawa N, Ishimaru T. Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. J Med Genet. 2004 Apr;41(4):289–292

PII: S1744-165X(07)00154-0

doi: 10.1016/j.siny.2007.12.008

Seminars in Fetal & Neonatal Medicine
Volume 13, Issue 2 , Pages 76-83 , April 2008

Article Tools

* Image Usage & Resolution